PATENT CLAIM ANALYSIS

Application Number: 16029198
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-02
Patent Classification: ["514", "183000"]

Abstract:
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of blood lipid therapy comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.

Claim (Index 4):
The method of  claim 1  wherein the subject has a triglyceride level of 750 mg/dl to about 2000 mg/dl.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13349150', '13735660', '13349157', '13610247', '13349153']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6969857898137722
- 35 USC 102 Novelty (BERT): 0.498544727813731
- Combined Prediction Score: 0.6771416836137681
- Mean Citation Score: 257.74883
- Max Citation Score: 282.4584
- Similarity Product: 254.1891514583588

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test